In recent years, research into cannabis and its main psychoactive ingredient, Δ⁹-tetrahydrocannabinol (THC), has unearthed medical benefits including anti-inflammatory and neuroprotective properties.

Celebrex contains the active ingredient celecoxib. It belongs to a group of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). This drug comes as a capsule that you swallow. The dose of ...

BACKGROUND AND OBJECTIVES: The objective of this study was to assess the bioequivalence between two 200 mg celecoxib hard capsule formulations administered to healthy male and female participants ...

Zydus Lifesciences (+0.13%) received final USFDA approval on July 15, 2025, to market Celecoxib Capsules (50 mg, 100 mg, 200 mg, and 400 mg) as generics of Celebrex®. The capsules will be manufactured ...

Zydus Lifesciences has received final approval from the US Food and Drug Administration (USFDA) to market Celecoxib Capsules in the U.S. market. The approval covers four dosage strengths — 50 mg, 100 ...

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg (USRLD: Celebrex ...

Ahmedabad: Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) ...

More Than 3,000 Bottles of a Trusted Pain Reliever and Fever Reducer Have Been Recalled Nationwide Over 20,000 Bottles of a Pain & Fever Reducer Have Been Recalled Nationwide More Than 3,000 Bottles ...

Strides Pharma Global, Singapore, has received approval for celecoxib capsules, 100 mg, 200 mg and 400 mg from the Food and Drug Administration. The product is the generic of Upjohn’s Celebrex. The ...

Strides Pharma has said that its step-down wholly owned subsidiary, Strides Pharma Global Pte., Singapore, has received approval for celecoxib capsules, 100 mg, 200 mg, and 400 mg, from the United ...

Strides Pharma Science (-0.31%) announced that its Singapore-based step-down wholly-owned subsidiary received approval from the USFDA for Celecoxib Capsules in strengths of 100 mg, 200 mg, and 400 mg.

Strides Pharma Science Limited has informed the Exchange regarding a press release dated April 30, 2025, titled Strides Strengthens Anti-Inflammatory Portfolio with USFDA Approval for Celecoxib ...